FDA Approved: LATANOPROST — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for latanoprost filed by Mylan Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Latanoprost (Latanoprost)

Snippet

SUPPL AP for LATANOPROST (LATANOPROST)